Clinical Trials Logo

Gastric pH Control clinical trials

View clinical trials related to Gastric pH Control.

Filter by:
  • None
  • Page 1

NCT ID: NCT01499693 Withdrawn - Gastric pH Control Clinical Trials

Magnesium Pantoprazole 20mg b.i.d. vs Magnesium Pantoprazole 40mg q.d. on Intragastric Acid Inhibition

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if magnesium pantoprazole 20 mg twice a day (b.i.d.), maintains gastric pH above 4 during a longer percentage of time than magnesium pantoprazole 40 mg once a day (qd). This is a comparison between split dose concept and standard dose of proton pump inhibitors.